A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Por Lieberman, Jeffrey A, Dunbar, Geoffrey, Segreti, Anthony C, Girgis, Ragy R, Seoane, Frances, Beaver, Jessica S, Duan, Naihua, Hosford, David A
Publicado em 2013

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies

Por Miki, Takafumi, Zwingman, Theresa A., Wakamori, Minoru, Lutz, Cathy M., Cook, Susan A., Hosford, David A., Herrup, Karl, Fletcher, Colin F., Mori, Yasuo, Frankel, Wayne N., Letts, Verity A.
Publicado em 2008

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

Por Walling, David, Marder, Stephen R., Kane, John, Fleischhacker, W. Wolfgang, Keefe, Richard S. E., Hosford, David A., Dvergsten, Chris, Segreti, Anthony C., Beaver, Jessica S., Toler, Steven M., Jett, John E., Dunbar, Geoffrey C.
Publicado no Schizophr Bull (2016)